# OZEMPIC

NDC: 0169-1709
Generic name: oral semaglutide
Labeler / Manufacturer: Novo Nordisk Pharmaceutical Industries, LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20260427

FDA application: NDA213051

## Active ingredients

- SEMAGLUTIDE: 9 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-1709"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-1709